Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer.

Saved in:
Bibliographic Details
Title: Plasma Gelsolin Inhibits CD8+ T-cell Function and Regulates Glutathione Production to Confer Chemoresistance in Ovarian Cancer.
Authors: Asare-Werehene M; Department of Obstetrics & Gynecology, University of Ottawa, Ottawa, Ontario, Canada.; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Communal L; Centre de Recherche du CHUM et Institut du Cancer de Montréal, Département de Médecine, Université de Montréal, Montréal, Québec, Canada., Carmona E; Centre de Recherche du CHUM et Institut du Cancer de Montréal, Département de Médecine, Université de Montréal, Montréal, Québec, Canada., Han Y; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea., Song YS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea., Burger D; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Centre de Recherche du CHUM et Institut du Cancer de Montréal, Département de Médecine, Université de Montréal, Montréal, Québec, Canada., Mes-Masson AM; Centre de Recherche du CHUM et Institut du Cancer de Montréal, Département de Médecine, Université de Montréal, Montréal, Québec, Canada., Tsang BK; Department of Obstetrics & Gynecology, University of Ottawa, Ottawa, Ontario, Canada. btsang@ohri.ca.; Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Ontario, Canada.
Source: Cancer research [Cancer Res] 2020 Sep 15; Vol. 80 (18), pp. 3959-3971. Date of Electronic Publication: 2020 Jul 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-20-0788